| 1.84 0.02 (1.1%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.27 | 1-year : | 2.45 |
| Resists | First : | 1.94 | Second : | 2.09 |
| Pivot price | 1.89  |
|||
| Supports | First : | 1.7 | Second : | 1.41 |
| MAs | MA(5) : | 1.82 |
MA(20) : | 1.87 |
| MA(100) : | 1.99 |
MA(250) : | 2.35 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 22.4 |
D(3) : | 25.8 |
| RSI | RSI(14): 46.7 |
|||
| 52-week | High : | 3.58 | Low : | 1.7 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ STXS ] has closed above bottom band by 32.7%. Bollinger Bands are 9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.86 - 1.87 | 1.87 - 1.87 |
| Low: | 1.79 - 1.8 | 1.8 - 1.81 |
| Close: | 1.83 - 1.84 | 1.84 - 1.85 |
Stereotaxis, Inc. specializes in the development, manufacturing, and commercialization of robotic systems, specialized instruments, and information management solutions for interventional laboratories, serving both domestic and international markets. A cornerstone of their product portfolio is their robotic magnetic navigation (RMN) technology, embodied by the Genesis RMN and Niobe systems. These innovative platforms empower clinicians to perform intricate interventional procedures by precisely guiding catheters and guidewires, under image guidance, through the vasculature and heart chambers to specific treatment sites. The company further delivers Odyssey, an advanced real-time information system designed to facilitate the management, control, recording, and secure sharing of procedural data across various networks. For robotic interventional operating rooms, Stereotaxis offers the Imaging Model S X-ray system, a comprehensive single-plane X-ray unit complete with a c-arm, powered table, motorized boom, and high-definition monitors. Complementing its primary systems, Stereotaxis provides a range of disposable components and accessories. This includes QuikCAS, which enables automated, remote advancement of electrophysiology catheters, as well as various steerable tip diagnostic and ablation catheters like the CARTO RMT, CELSIUS RMT, and several NAVISTAR RMT models, some featuring irrigated tips. Additionally, they offer Vdrive, a system engineered to enhance the navigation and stability of diagnostic and therapeutic devices during interventional procedures, alongside disposable elements such as V-Loop, V-Sono, and V-CAS. Stereotaxis distributes its offerings through a combination of its dedicated direct sales force, distributors, and sales agents. The company has also forged a strategic alliance with Osypka AG to jointly develop a magnetic ablation catheter leveraging Stereotaxis' proprietary robotic technology. Founded in 1990, Stereotaxis, Inc. maintains its headquarters in Saint Louis, Missouri.
Mon, 08 Jun 2026
Stereotaxis Inc (NYSE: STXS) Share Price, STXS Stock News, STXS Share Price & Updates - Kalkine
Sun, 24 May 2026
Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why - Yahoo Finance
Wed, 13 May 2026
Stereotaxis (STXS) posts Q1 2026 loss and plans $20M Robocath acquisition - Stock Titan
Tue, 12 May 2026
Stereotaxis, Inc. (STXS) Reports Strong Q1 2026 Earnings and Gro - GuruFocus
Tue, 12 May 2026
Stereotaxis Inc. (STXS) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Thu, 23 Apr 2026
Stereotaxis Stock Up on First U.S. MAGiC Procedures Post Approval - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|